* If you want to update the article please login/register
Tumor formation and metastasis, according to a new study, the tumor microenvironment, which includes cancer cells and the surrounding stromal cells, plays a significant role in tumor formation and metastasis. Methods The samples were divided into cancer tissue and isolated cancer stromal tissue, according to the author's instructions. Using The Cancer Genome Atlas and 17 stromal tissues obtained from our lab via stromal isolation using an array-based analysis, the study investigated altered mRNA expression in the cancer tissues. In addition, 259 patients with CRC were recruited to see if there was an association of the candidate markers that were associated with patients with stage 2 or 3 CRC's prognosis. Results As a result, tenascin-C, unethical phosphoprotein 1 and laminin were present in metastatic CRC cells, olfactory receptors 11H1 and OR11H4 were present in stromal tissue cells isolated from metastatic CRC samples isolated from metastatic CRC cells.
Source link: https://doi.org/10.1245/s10434-022-12574-1
Background: Background - Cancer screening rates in Latino areas are still low. We interviewed 150 Latinos at urban federally qualified Health Center from June-October 2017, July-October 2017. Anyone over the age of 50+, access to a primary care facility, and knowing the screening process were both associated with ever having a colonoscopy. Any CRC screening was a good predictor of a high knowledge score. Discussion Knowledge About CRC screening Guidelines and Options To make CRC screening more available, it would be useful to inform this population. Optimization Screening Intolerance screening guidelines and options should be performed by professionals, so if screening is needed, efforts should be carried out.
Source link: https://doi.org/10.1007/s10903-022-01358-0
We then developed a methylation signature risk-scoring scheme to identify SyCRC in uncontrolled cohort of 38 SyCRC and 42 SoCRC patients. We developed a methylation panel that identified patients with SyCRC from not only the larger tumor but also the paired remaining tumor in the validation study. In addition, high risk scores of our panel were correlated with the development of metachronous CRC among patients with SyCRC, and became an early predictor of relapse-free survival. In addition, the risk stratification model, which was combined with medical risk factors, was a diagnostic predictor of recurrence.
Source link: https://doi.org/10.1038/s41416-022-02033-9
BRAF V600E mutant colorectal cancer's prognosis is poor, but the CRC's prognostic implications of immune contextures in the tumour microenvironment remain elusive. Methods We collected the primary tumor specimens and clinicopathological data of patients with de novo metastatic microsatellite-stable BRAF V600E mutant CRC from two medical centers. The Cox proportional hazards regression model was used to examine survival results in association with immune gene expression and immune cells. Conclusions Complement activation in the TME was strongly associated with poor OS and was directly linked to TAM M2 in patients with de novo metastatic BRAF V600E mutant CRC.
Source link: https://doi.org/10.1038/s41416-022-02010-2
Objection: Nearly one-third of patients diagnosed with colorectal cancer will eventually have metastatic disease. Although a small number of patients may be deemed for curative resection, many patients have limited disease that could be considered for local therapy. Methods We present the current literature on treating and evaluating local therapy in patients with metastatic CRC in this review. Long-Term Protection and Overall Survival For patients with liver- and/or lung-confined CRC metastases, surgical resection is the standard of care, with the promise of long-term progression-free and overall survival. Metastasis-directed therapy is controversial among patients with more advanced illness, such as lymph node or bony metastases. With ongoing research including the RESOLUTE trial and the forthcoming NCTN ERASur trial, high-quality prospective randomized studies in CRC are needed to further clarify the role of local ablative therapy in patients with unresectable oligometastatic CRC.
Source link: https://doi.org/10.1007/s12029-022-00900-5
Despite the initial success of chemotherapy in the treatment of colorectal carcinoma, the disease's recurrence shows that tumor responses are limited by drug resistance and cannot be kept under control. Combination therapy with other anticancer drugs may have an effect on combined therapies' therapeutic success by allowing the use of lower, less toxic doses to achieve more effective cancer cell destruction. Several cancer cells have been tested with other anticancer cell inhibitory agents, and it has been shown to sensitize the cytotoxicity caused by various anticancer drugs in several cancer cells. The CompuSyn device was used to analyze different Cis + LU combinations in HCT116 colorectal cancer cells in this research. Luteolin can therefore be used in medicine to provide more effective cancer therapy in appropriate doses, which indicates a promising future in clinical use.
Source link: https://doi.org/10.1007/s10895-023-03145-y
This paper sought to report quantitatively the results of machine learning-based radiomics models in the analysis of microsatellite variability in patients with colorectal cancer. Preoperative CT/MRI/PET-CT images were used by RTI to determine the MSI status in CRC patients with no history of anti-tumor therapy was eligible. To determine the research's quality, the radiomics quality score and Quality Assessment of Diagnostic Accuracy Studies 2 were used. In the external validation cohort, the model's area under the receiver operator curve varied from 0. 78 to 0. 96. In conclusion, although radiomics based on pretreatment imaging techniques displayed a high success in the prediction of MSI status in CRC, the study does not appear to be suitable for clinical use due to insufficient methodological consistency.
Source link: https://doi.org/10.1007/s11547-023-01593-x
This review examined the perioperative and long-term oncologic outcomes of elderly patients undergoing colorectal surgery. Patients older than 65 years at the time of colorectal resection at Roswell Park Comprehensive Cancer Center between July 2011 and September 2020 were identified. The updated Risk Analysis Index score was used to identify frail patients using variations from the National Surgical Quality Improvement Program, the tumor registry, and electronic medical registry to determine frail patients using the new Risk Analysis Index score. Oncologic results were evaluated in 318 patients with colorectal adenocarcinoma undergoing curative-intent resection. Except for frail patients with stage 0 or 1 adenocarcinoma, who had shorter overall survival, disease-specific survival, or progression-free survival, there were no differences with frailty in terms of general survival, disease-specific survival, or progression-free survival, but similar other outcomes were observed in other contexts. Frailty has no effect on long-term oncologic outcomes, so frail elderly patients receive the same oncologic benefit with surgery as non-frail patients.
Source link: https://doi.org/10.1245/s10434-022-12970-7
Background The pathogenic effect of colorectal tumor molecular features may be affected by several factors, including those related to microbiota, inflammation, metabolism, and epigenetics, which may vary among colorectal segments. We speculated that the prognostic association of colon cancer location could vary based on tumor molecular characteristics. Results From the cecum to sigmoid colony, there was a statistically significant trend for improved colon cancer-specific survival in relation to tumor location, but not the rectum. The prognostic association of colon tumor location also differed by CIMP status, but not significantly by age, stage, or other characteristics, as illustrated. Both the geographical location and tumor molecular characteristics of colon cancer prognostication are important in order to advance precision medicine.
Source link: https://doi.org/10.1007/s00535-023-01955-2
Background Chemotherapy resistance is a significant bottleneck that can influence chemotherapy's efficacy in colon cancer. Hence, increasing the sensitivity of colorectal cancer cells in chemotherapy is of utmost importance in reducing colon cancer prognosis. Methods CCK-8 assay was used to determine the cell viability of colorectal cancer cell lines. TLR4 proteins were discovered in the stems of the colorectal cancer cell lines by infecting cells with TLR4 siRNA. Aspirin can effectively raise the chemosensitivity of CT26 and HCT116 colorectal cancer cell lines, according to the authors. Besides that, aspirin has also contributed to a decrease in TLR4 expression in colorectal cancer cells. The TLR4 positive colorectal cancer cells had a greater chemotherapy resistance potential than TLR4 negative colorectal cancer cells, according to TLR4 positive colorectal cancer cells. In addition, the stemness of TLR4 positive colorectal cancer cells is higher than that of TLR4 negative colorectal cancer cells.
Source link: https://doi.org/10.1186/s12935-023-02847-4
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions